Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53.

@article{Beenken2001MolecularBF,
  title={Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53.},
  author={Samuel W. Beenken and William E. Grizzle and David R. Crowe and Michael G. Conner and Heidi L. Weiss and Marty T. Sellers and Helen Krontiras and Marshall M. Urist and Kirby I. Bland},
  journal={Annals of surgery},
  year={2001},
  volume={233 5},
  pages={630-8}
}
OBJECTIVE To assess the prognostic significance of molecular biomarkers, particularly c-erbB-2 and p53, through study of prospective clinical data and archival breast cancer tissues for women accrued to the Alabama Breast Cancer Project. SUMMARY BACKGROUND DATA Defining molecular abnormalities in breast cancer is an important strategy for early detection, assessment of prognosis, and treatment selection. Evidence is strong that selective biomarkers, including c-erbB-2 and p53, have prognostic… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

Similar Papers

Loading similar papers…